Skip to main content
Home

Funding-related barriers preventing many radiology residency programs from expanding

scanner money radiology dollar MRI CT payment compensation

According to data presented at RSNA, the capacity to expand prgrams exists, but the funds do not.

  • Read more about Funding-related barriers preventing many radiology residency programs from expanding

Interventional cardiology groups unite to push the specialty forward

Heart doctors and surgeons working together. Top cardiology hospitals in the United States.

SCAI and CRT have announced a new partnership focused on education, advocacy and research.

  • Read more about Interventional cardiology groups unite to push the specialty forward

3-in-1 TAVR guidewire linked to faster procedures, less radiation

SavvyWire OpSens TAVR guidewire owned by Haemonetics. the SavvyWire guidewire, a sensor-guided device developed by OpSens Medical, a Canadian medical device company. According to OpSens, the SavvyWire is the first interventional device of its kind. It provides assistance with aortic valve delivery and positioning, like any guidewire, but it also includes sensors that enable continuous hemodynamic measurements and rapid LV pacing.

The sensor-guided device delivers continuous hemodynamic measurements and rapid left ventricular pacing during TAVR procedures. Back in 2023, it was at the heart of a $253 million acquisition. 

  • Read more about 3-in-1 TAVR guidewire linked to faster procedures, less radiation

Ultrasound is both the prevention and solution for cosmetic filler-related injuries

When fillers are injected without imaging guidance, there is a risk that the materials could be misplaced. A common complication of this scenario is vascular occlusion, which occurs when filler is injected in a way that disrupts bloodflow to arteries. 

  • Read more about Ultrasound is both the prevention and solution for cosmetic filler-related injuries

Stem cell company acquires 2 cardiology practices, calling them ‘the first of many’

merger acquisition M&A business

Hemostemix believes its new cell therapy platform can help treat peripheral artery disease, congestive heart failure, cardiomyopathy and other serious medical conditions. The company plans on scooping up multiple practices to conduct additional research and increase the use of its platform. 

  • Read more about Stem cell company acquires 2 cardiology practices, calling them ‘the first of many’

FDA announces Class I recall of patches used for heart surgery

FDA recall medical device recall product recall

There is a risk of certain pericardial patches not being as strong or durable as needed. Customers are urged to identify, quarantine and replace these devices.

  • Read more about FDA announces Class I recall of patches used for heart surgery

Data show ‘alarming’ rise in invasive breast cancer cases among younger women

mammogram mammography breast cancer

Between 20% to 24% of all breast cancers diagnosed during a decade-long period were found in women between the ages of 18 to 49, according to research presented at RSNA 2025. 

  • Read more about Data show ‘alarming’ rise in invasive breast cancer cases among younger women

Beloved radiologist and his wife killed in apparent murder-suicide

Vicki and Eric Cordes, MD

Vicki Cordes, 66, and Eric Cordes, MD, 63

Eric Cordes, MD, 63, of Simi Valley, California, was a highly respected diagnostic specialist with Adventist Health Simi Valley and Focus Medical Imaging. 

  • Read more about Beloved radiologist and his wife killed in apparent murder-suicide

Renowned radiologist Jeffrey Klein, MD, named RSNA board president

Jeffrey S. Klein, MD

Jeffrey S. Klein, MD

A consultant at the VA White River Junction Healthcare System in Vermont, Klein is a noted expert in the diagnosis and staging of lung cancer. 

  • Read more about Renowned radiologist Jeffrey Klein, MD, named RSNA board president

Lumexa Imaging eyes up to $1.89B company valuation in IPO

stock market IPO

The Raleigh, North Carolina-based company—previously known as US Radiology Specialists—hopes to raise as much as $500 million through the IPO, 

  • Read more about Lumexa Imaging eyes up to $1.89B company valuation in IPO

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …128
    • Page 129
    • Page 130
    • Page 131
    • Current page 132
    • Page 133
    • Page 134
    • Page 135
    • Page 136 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme